Long-term outcome after early cyclosporine withdrawal in kidney transplantation: ten years after.
Tabibzadeh, Nahid; Glowacki, François; Frimat, Marie; Elsermans, Vincent; Provôt, François; Lionet, Arnaud; Gnemmi, Viviane; Hertig, Alexandre; Noël, Christian; Hazzan, Marc.
; 30(11): 1480-1487, 2016 11.
Artigo em Inglês | MEDLINE | ID: mdl-27623348
Calcineurin inhibitor minimisation versus continuation of calcineurin inhibitor treatment for liver transplant recipients.
Mycophenolate mofetil versus methotrexate for prevention of graft-versus-host disease in people receiving allogeneic hematopoietic stem cell transplantation.
Belatacept for kidney transplant recipients.
Impact of type of calcineurin inhibitor on post-transplant tuberculosis: Single-center study from India.
Everolimus and reduced calcineurin inhibitor therapy in pediatric liver transplant recipients: Results from a multicenter, prospective study.
Cyclosporine in psoriatic arthropathy.
Calcineurin inhibitor sparing in paediatric solid organ transplantation : managing the efficacy/toxicity conundrum.
Progressive decline in tacrolimus clearance after renal transplantation is partially explained by decreasing CYP3A4 activity and increasing haematocrit.
Everolimus with cyclosporine withdrawal or low-exposure cyclosporine in kidney transplantation from Month 3: a multicentre, randomized trial.
De novo cancer avoidance after renal transplantation: A case-control study on low-dose sirolimus combined with a calcineurin inhibitor.